Targeted Medical Pharma (United States)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Mathematics 14.9×
• Economics, Econometrics and Finance 7.6×
• Biochemistry, Genetics and Molecular Biology 5.1×
• Immunology and Microbiology 2.9×
• Medicine 1.8×
• Health Professions 0.7×

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, AAV, Viral Vectors, Glycosylation, Monoclonal Antibody, Epidemiology, Immunotherapy and Tumor Regression.

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, BRCA gene mutations in cancer, Genomics and Rare Diseases and Statistical Methods and Inference.

1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
2. 2 BRCA gene mutations in cancer Genetics 0 works
3. 3 Genomics and Rare Diseases Genetics 0 works
4. 4 Statistical Methods and Inference Statistics and Probability 0 works
5. 5 Colorectal Cancer Treatments and Studies Oncology 0 works
6. 6 Advanced Causal Inference Techniques Statistics and Probability 0 works
7. 7 Statistical Methods and Bayesian Inference Statistics and Probability 0 works
8. 8 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 0 works
9. 9 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
10. 10 Colorectal Cancer Surgical Treatments Oncology 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 20% higher than in 2013–2017.

• University of California, Los Angeles
• University of Southern California
• Cedars-Sinai Medical Center
• Film Independent
• UCLA Health
• Children's Hospital of Los Angeles
• California State University Los Angeles
• Loyola Marymount University